0000000000754407
AUTHOR
B. Holzgraefe
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5)
The members of the LUNG SAFE Investigators and the ESICM Trials Group were provided in such a way that they could not be indexed as collaborators on PubMed. The publisher apologizes for this error.
Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study
Purpose: To evaluate patients with resolved versus confirmed ARDS, identify subgroups with substantial mortality risk, and to determine the utility of day 2 ARDS reclassification. Methods: Our primary objective, in this secondary LUNG SAFE analysis, was to compare outcome in patients with resolved versus confirmed ARDS after 24 h. Secondary objectives included identifying factors associated with ARDS persistence and mortality, and the utility of day 2 ARDS reclassification. Results: Of 2377 patients fulfilling the ARDS definition on the first day of ARDS (day 1) and receiving invasive mechanical ventilation, 503 (24%) no longer fulfilled the ARDS definition the next day, 52% of whom initial…
Der Einfluß von exogenem Laktat auf gemessene Plasmalaktatspiegel im hämorrhagischen Schock — eine kontrollierte Studie am Schwein
Einleitung: Seit mehr als 40 Jahren wird Laktat den Kristalloid-Losungen als Anion zugesetzt und als Plasmasubstitut in Form des Ringer-Laktats weltweit eingesetzt. Zur Beurteilung einer anaeroben Stoffwechselsituation und als prognostischer Parameter kommt dem Plasmalaktatspiegel klinisch eine wichtige Bedeutung zu.